News

UroToday7h
ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia
In Q1, the company submitted a supplemental Biologics License Application (sBLA) for use of ANKTIVA® plus Bacillus Calmette-Guérin (BCG) in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) ...
UroToday22h
When Should We Use 18F-FDG PET? "Presentation" - Andrei Iagaru
When Should We Use 18F-FDG PET? "Presentation" - Andrei Iagaru ...
UroToday1d
APCCC Diagnostics 2025: Monitoring of Patients on PSMA-Radioligand Therapy
(UroToday.com) The 2025 APCCC Diagnostics annual meeting featured a session on how to monitor metastatic prostate cancer and a presentation by Dr. Andrei Iagaru discussing monitoring of patients on ...
UroToday1d
EAU 2025: Trial Update Intensified Approaches with Triple Therapy Other than Taxanes
(UroToday.com) The 2025 European Association of Urology (EAU) Annual Meeting held in Madrid, Spain, was host to the clinically relevant questions in the management of advanced, hormone-sensitive ...